semaglutide for pcos insulin resistance and metformin improve menstrual cyclicity in overweight/obese women with polycystic ovary syndrome: a randomized trial What You Must Know About

Its also used to reduce the risk of cardiovascular problems in people with both Type 2 diabetes and heart disease

doi:10.1369/0022155413497586 70

These observations are consistent with those from similar post-hoc analyses of patients receiving glucose-lowering background medication in the clinical trial programme for once-weekly subcutaneous semaglutide (SUSTAIN 24 and 10) [17]

doi: 10.1016/j.ajpc.2024.100679 PMID: 38779187 Vosoughi K et al (2022): Effects of GLP-1 agonists on proportion of weight loss in obesity with or without diabetes: Systematic review and meta-analysis

Is Retatrutide available for purchase in Canada